InvestorsHub Logo
Followers 7
Posts 263
Boards Moderated 0
Alias Born 09/30/2015

Re: tob999 post# 41

Saturday, 11/14/2015 8:33:05 PM

Saturday, November 14, 2015 8:33:05 PM

Post# of 363

AXON have a duff AD drug that GlaxoSmithKline sold them for a paltry $5M.



All the bear articles and comments just talks about initial $5M payment to GSK and leaving out the rest of the deal which is 12.5% sales royalty to GSK as well as $75-$160 million in contingent payments to GSK upon reaching several milestones. Looks like a great deal for GSK.